faster product development due to harmonized products ✓ flexible development and application due to broad portfolio ✓ comprehensive fields of application for various technologies more
Bruker Announces Acquisition of Canopy Biosciences, LLC
Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s global reach more
Could the blood of COVID-19 patients be used to predict disease progression?
Researchers from Charité – Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms. These biomarker profiles could be used to predict disease progressio more
Amplification and imaging of microRNA as a biomarker to detect tumor development
A good indicator of dysregulation in live cells is a change in their RNA expression. MicroRNA (miRNA), a special type of RNA, is considered a biomarker for carcinogenic cells. A team of scientists from China has found a way to amplify miRNA in live tumor cells for bioimaging. As they report in the j more